Last Updated: November 10, 2026

Alkem Labs Ltd Company Profile

« Back to Dashboard


What is the competitive landscape for ALKEM LABS LTD

ALKEM LABS LTD has one hundred and forty-four approved drugs.

There are eleven tentative approvals on ALKEM LABS LTD drugs.

Summary for Alkem Labs Ltd
US Patents:0
Tradenames:118
Ingredients:117
NDAs:144

Drugs and US Patents for Alkem Labs Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 206145-002 Oct 22, 2018 AB RX No Yes ⤷  Start Trial ⤷  Start Trial
Alkem Labs Ltd DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE dapagliflozin; metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 211563-002 Apr 6, 2026 AB RX No No ⤷  Start Trial ⤷  Start Trial
Alkem Labs Ltd DEFERASIROX deferasirox TABLET, FOR SUSPENSION;ORAL 210519-003 Nov 20, 2019 AB RX No No ⤷  Start Trial ⤷  Start Trial
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-002 May 31, 1985 AB RX Yes Yes ⤷  Start Trial ⤷  Start Trial
Alkem Labs Ltd LINEZOLID linezolid TABLET;ORAL 205517-001 Dec 21, 2015 AB RX No Yes ⤷  Start Trial ⤷  Start Trial
Alkem Labs Ltd CARBAMAZEPINE carbamazepine TABLET, EXTENDED RELEASE;ORAL 217277-001 Jan 14, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Alkem Labs Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-001 May 31, 1985 6,703,418 ⤷  Start Trial
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-003 May 31, 1985 6,703,418 ⤷  Start Trial
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-002 May 31, 1985 6,703,418 ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.